TARGET AC A prospective multicenter randomized post-market trial evaluating a novel Cobalt Chrome Rapamycin Drug Eluting Stent
Presenter: Andreas Baumbach
REGISTER for free or LOG IN to view this content
Become a GOLD or PLATINUM member to access PowerPoint files, presentation audio, and video